ZNTL – zentalis pharmaceuticals, inc. - common stock (US:NASDAQ)
Stock Stats
News
Zentalis Pharmaceuticals Reports Full Year 2025 Financial Results and Operational Updates
Zentalis Pharmaceuticals to Present Two Posters at the American Association for Cancer Research (AACR) Annual Meeting 2026 [Yahoo! Finance]
Zentalis Pharmaceuticals to Present Two Posters at the American Association for Cancer Research (AACR) Annual Meeting 2026
Zentalis Pharmaceuticals (ZNTL) is now covered by Wells Fargo & Company. They set an "equal weight" rating and a $5.00 price target on the stock.
Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences
Form 10-K Zentalis Pharmaceuticals For: Dec 31
Form 8-K Zentalis Pharmaceuticals For: Mar 26
Form SCHEDULE 13G Zentalis Pharmaceuticals Filed by: Squadron Capital Management LLC
Form 4 Zentalis Pharmaceuticals For: Feb 06 Filed by: Bruns Ingmar
Form 4 Zentalis Pharmaceuticals For: Feb 06 Filed by: Vultaggio Vincent
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.